Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Fund Type: Unit Trust
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Global

AXA Framlington Biotech Fund

+ Add to Watchlist

FRABIOZ:LN

299.10 GBp 3.70 1.22%

As of 00:59:30 ET on 01/28/2015.

Snapshot for AXA Framlington Biotech Fund (FRABIOZ)

Year To Date: +10.08% 3-Month: +21.83% 3-Year: - 52-Week Range: 173.61 - 302.80
1-Month: +13.73% 1-Year: +52.10% 5-Year: - Beta vs NBI: 0.94

Mutual Fund Chart for FRABIOZ

No chart data available.
  • FRABIOZ:LN 299.10
  • 1M
  • 1Y
Interactive FRABIOZ Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for FRABIOZ

AXA Framlington Biotech Fund is an authorized unit trust incorporated in the United Kingdom. The aim of the Fund is to provide long-term capital appreciation The Fund will invest principally in equity securities of companies in the biotechnology, genomic and medical research industries worldwide.

Inception Date: 04-16-2012 Telephone: 44-207-374-4100
Managers: LINDEN THOMSON / GEMMA GAME
Web Site: www.axa-framlington.com

Fundamentals for FRABIOZ

NAV (on 2015-01-28) 299.10
Assets (M) (on 2014-11-27) 477.91
Fund Leveraged N
Minimum Investment 100,000.00
Minimum Subsequent Investment 5,000.00

Dividends for FRABIOZ

Dividend Type Omitted
Dividend Frequency Semi-Anl
Last Dividend Net -
Dividend Yield (ttm) -

Fees & Expenses for FRABIOZ

Front Load 0.00
Back Load -
Current Mgmt Fee 0.75
Redemption Fee -
12b1 Fee -
Expense Ratio -

Top Fund Holdings for FRABIOZ

Filing Date: 12/31/2014
Name Position Value % of Total
Biogen Idec Inc 234,180 51,018,800 9.800%
Celgene Corp 659,882 47,374,600 9.100%
Amgen Inc 422,658 43,209,800 8.300%
Gilead Sciences Inc 645,406 39,045,000 7.500%
Vertex Pharmaceuticals Inc 334,564 25,509,400 4.900%
Regeneron Pharmaceuticals Inc 86,997 22,906,400 4.400%
Alexion Pharmaceuticals Inc 192,890 22,906,400 4.400%
Illumina Inc 188,966 22,385,800 4.300%
BioMarin Pharmaceutical Inc 287,132 16,659,200 3.200%
Incyte Corp 332,846 15,618,000 3.000%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil